Washington Post:
A drug to treat breast cancer received approval yesterday from the Food and Drug Administration, which went against the recommendation of its advisory panel.
Avastin is already approved for treating lung and colon cancer. The FDA gave preliminary approval to doctors' use of the drug, made by Genentech, to treat breast cancer based on findings that it slowed tumor growth.
FDA approval for late-stage cancer treatments is usually contingent upon data showing that a drug extended patients' lives or improved their quality. Avastin showed neither in a study, according to Genentech.....
In other words, Avastin did not extend lives or revive the quality of life. Why did it get approval? Do you think it had to do with some lobbyists pushing for its approval?